Jeffrey Robert Friedman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothalamus | 9 | 2010 | 1063 | 0.610 |
Why?
|
| Leptin | 9 | 2011 | 1593 | 0.550 |
Why?
|
| Founder Effect | 4 | 2011 | 190 | 0.380 |
Why?
|
| Neuropeptide Y | 6 | 2007 | 200 | 0.370 |
Why?
|
| Micronesia | 10 | 2010 | 43 | 0.330 |
Why?
|
| Neurons | 12 | 2010 | 9325 | 0.320 |
Why?
|
| Genome, Human | 5 | 2011 | 4420 | 0.320 |
Why?
|
| Pro-Opiomelanocortin | 4 | 2005 | 163 | 0.320 |
Why?
|
| Haplotypes | 5 | 2011 | 2781 | 0.310 |
Why?
|
| Fasting | 4 | 2007 | 1589 | 0.300 |
Why?
|
| Receptors, Neuropeptide | 2 | 2005 | 111 | 0.280 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2005 | 48 | 0.260 |
Why?
|
| Microdissection | 1 | 2005 | 152 | 0.250 |
Why?
|
| Hypothalamic Hormones | 1 | 2006 | 147 | 0.250 |
Why?
|
| Pituitary Hormones | 1 | 2006 | 183 | 0.250 |
Why?
|
| Eating | 6 | 2007 | 1535 | 0.250 |
Why?
|
| Receptors, Cell Surface | 3 | 2001 | 2867 | 0.240 |
Why?
|
| Mice, Obese | 9 | 2011 | 424 | 0.240 |
Why?
|
| Lasers | 2 | 2005 | 952 | 0.240 |
Why?
|
| Melanins | 1 | 2006 | 288 | 0.230 |
Why?
|
| Receptor, Melanocortin, Type 4 | 5 | 2010 | 129 | 0.230 |
Why?
|
| Genetics, Medical | 1 | 2006 | 337 | 0.220 |
Why?
|
| Thinness | 1 | 2006 | 479 | 0.210 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2002 | 86 | 0.210 |
Why?
|
| Receptors, Leptin | 5 | 2010 | 356 | 0.200 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2001 | 26 | 0.190 |
Why?
|
| Microsatellite Repeats | 3 | 2006 | 800 | 0.190 |
Why?
|
| Genetic Linkage | 1 | 2006 | 2422 | 0.180 |
Why?
|
| Mice, Transgenic | 15 | 2011 | 9735 | 0.180 |
Why?
|
| Energy Metabolism | 4 | 2006 | 2896 | 0.180 |
Why?
|
| Population Groups | 2 | 2011 | 208 | 0.180 |
Why?
|
| Chromosome Mapping | 6 | 2011 | 4742 | 0.180 |
Why?
|
| Action Potentials | 2 | 2005 | 1814 | 0.180 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2000 | 144 | 0.180 |
Why?
|
| Neuronal Plasticity | 2 | 2005 | 1418 | 0.180 |
Why?
|
| Genome-Wide Association Study | 6 | 2011 | 12220 | 0.180 |
Why?
|
| Hyperlipidemias | 2 | 2004 | 786 | 0.180 |
Why?
|
| Dyslipidemias | 1 | 2006 | 848 | 0.160 |
Why?
|
| Obesity | 4 | 2006 | 12705 | 0.160 |
Why?
|
| Quantitative Trait Loci | 1 | 2006 | 2015 | 0.160 |
Why?
|
| Nerve Net | 3 | 2006 | 2174 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2011 | 15494 | 0.140 |
Why?
|
| Alleles | 6 | 2011 | 6931 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 6 | 2010 | 2088 | 0.140 |
Why?
|
| Weight Loss | 3 | 2011 | 2604 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 2 | 2006 | 4465 | 0.130 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 261 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 1 | 2000 | 562 | 0.130 |
Why?
|
| Brain Mapping | 3 | 2005 | 6669 | 0.130 |
Why?
|
| Gene Frequency | 5 | 2011 | 3587 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1996 | 657 | 0.120 |
Why?
|
| Genetics, Population | 2 | 2009 | 933 | 0.120 |
Why?
|
| Carrier Proteins | 5 | 2003 | 5019 | 0.120 |
Why?
|
| Viral Proteins | 1 | 2001 | 1899 | 0.110 |
Why?
|
| Hypertension | 2 | 2006 | 8455 | 0.110 |
Why?
|
| Pacific Islands | 2 | 2011 | 50 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 791 | 0.110 |
Why?
|
| Luminescent Proteins | 4 | 2004 | 853 | 0.110 |
Why?
|
| Gene Expression | 6 | 2010 | 7790 | 0.110 |
Why?
|
| Mice | 22 | 2011 | 81045 | 0.110 |
Why?
|
| Feeding Behavior | 4 | 2011 | 3187 | 0.100 |
Why?
|
| RNA, Messenger | 9 | 2010 | 13029 | 0.100 |
Why?
|
| Proteins | 3 | 2010 | 6096 | 0.100 |
Why?
|
| Pedigree | 3 | 2009 | 4646 | 0.100 |
Why?
|
| Liver | 3 | 2010 | 7470 | 0.100 |
Why?
|
| Receptor, Melanocortin, Type 3 | 2 | 2011 | 15 | 0.100 |
Why?
|
| Genotype | 8 | 2011 | 12946 | 0.100 |
Why?
|
| In Situ Hybridization | 4 | 2010 | 1950 | 0.100 |
Why?
|
| Anticipation, Psychological | 1 | 2011 | 87 | 0.100 |
Why?
|
| Hemoglobins | 1 | 1996 | 1532 | 0.090 |
Why?
|
| Nodose Ganglion | 1 | 2010 | 8 | 0.090 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 2010 | 13 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 5724 | 0.090 |
Why?
|
| Water | 1 | 1996 | 1388 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 4 | 2005 | 963 | 0.090 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2009 | 369 | 0.090 |
Why?
|
| Gene Pool | 1 | 2009 | 35 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 10 | 2011 | 21821 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2009 | 17400 | 0.090 |
Why?
|
| Mice, Inbred CBA | 3 | 2009 | 447 | 0.090 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 340 | 0.090 |
Why?
|
| Sterols | 1 | 2009 | 63 | 0.090 |
Why?
|
| Vagus Nerve | 2 | 2010 | 437 | 0.090 |
Why?
|
| Sexual Maturation | 1 | 2010 | 265 | 0.080 |
Why?
|
| Phytosterols | 2 | 2009 | 65 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2008 | 58 | 0.080 |
Why?
|
| Animals | 24 | 2011 | 168561 | 0.080 |
Why?
|
| Postprandial Period | 1 | 2010 | 292 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2004 | 3861 | 0.080 |
Why?
|
| Motor Activity | 2 | 2011 | 2714 | 0.080 |
Why?
|
| Geography | 1 | 2009 | 669 | 0.070 |
Why?
|
| Receptors, Melanocortin | 1 | 2006 | 25 | 0.070 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2006 | 38 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 12071 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2005 | 1221 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 3770 | 0.070 |
Why?
|
| Trans-Activators | 1 | 1996 | 2924 | 0.070 |
Why?
|
| Family Relations | 1 | 2008 | 321 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2011 | 6540 | 0.070 |
Why?
|
| Machado-Joseph Disease | 1 | 2006 | 26 | 0.070 |
Why?
|
| Peptide Hormones | 2 | 2004 | 134 | 0.070 |
Why?
|
| Disease | 1 | 2011 | 681 | 0.070 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2005 | 46 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2009 | 559 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5867 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2009 | 850 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2007 | 494 | 0.060 |
Why?
|
| Lipid Metabolism | 2 | 2004 | 1887 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2003 | 126 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2004 | 81 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2008 | 1995 | 0.060 |
Why?
|
| Enkephalin, Methionine | 1 | 2004 | 26 | 0.060 |
Why?
|
| Brain | 5 | 2009 | 26343 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9639 | 0.060 |
Why?
|
| Steroids | 1 | 2009 | 931 | 0.060 |
Why?
|
| Receptors, Corticotropin | 1 | 2003 | 25 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2009 | 914 | 0.060 |
Why?
|
| Body Weight | 3 | 2004 | 4664 | 0.060 |
Why?
|
| Baclofen | 1 | 2004 | 128 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1581 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2009 | 1048 | 0.060 |
Why?
|
| Apolipoprotein A-I | 2 | 2002 | 280 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2008 | 1118 | 0.060 |
Why?
|
| Glutamic Acid | 2 | 2005 | 1167 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2007 | 429 | 0.050 |
Why?
|
| Exons | 1 | 2008 | 2431 | 0.050 |
Why?
|
| Markov Chains | 1 | 2006 | 969 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2009 | 3493 | 0.050 |
Why?
|
| Microsomes, Liver | 1 | 2002 | 175 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 1866 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4187 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2005 | 766 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2009 | 6440 | 0.050 |
Why?
|
| Ion Channels | 1 | 2007 | 1056 | 0.050 |
Why?
|
| Serotonin | 1 | 2006 | 1024 | 0.050 |
Why?
|
| Vacuoles | 1 | 2002 | 230 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2010 | 11363 | 0.050 |
Why?
|
| Lipoproteins, VLDL | 1 | 2002 | 201 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2006 | 12164 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2005 | 1154 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2006 | 1254 | 0.050 |
Why?
|
| Heart Murmurs | 1 | 2000 | 94 | 0.050 |
Why?
|
| Insulin | 3 | 2006 | 6575 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 995 | 0.050 |
Why?
|
| Male | 19 | 2010 | 349538 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 867 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 5851 | 0.050 |
Why?
|
| Cell Death | 1 | 2006 | 1695 | 0.050 |
Why?
|
| Adipose Tissue | 2 | 2006 | 3278 | 0.050 |
Why?
|
| Noonan Syndrome | 1 | 2000 | 120 | 0.050 |
Why?
|
| Afferent Pathways | 1 | 2001 | 302 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2006 | 942 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2723 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 598 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2006 | 728 | 0.040 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2000 | 183 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 1121 | 0.040 |
Why?
|
| Body Height | 1 | 2006 | 1574 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2004 | 876 | 0.040 |
Why?
|
| Apolipoproteins B | 1 | 2001 | 373 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2009 | 874 | 0.040 |
Why?
|
| Synapses | 2 | 2005 | 1724 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3920 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2008 | 2354 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2006 | 6249 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 2267 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2005 | 2027 | 0.040 |
Why?
|
| Mitral Valve Prolapse | 1 | 2000 | 230 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2010 | 2971 | 0.040 |
Why?
|
| Integrases | 1 | 2001 | 533 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 2000 | 281 | 0.040 |
Why?
|
| Female | 17 | 2010 | 379592 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2007 | 14554 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2001 | 975 | 0.040 |
Why?
|
| Energy Intake | 1 | 2006 | 2147 | 0.040 |
Why?
|
| Heart Rate | 1 | 2009 | 4091 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2011 | 6191 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.040 |
Why?
|
| Lipoprotein Lipase | 1 | 1997 | 125 | 0.040 |
Why?
|
| Bivalvia | 1 | 1996 | 53 | 0.040 |
Why?
|
| Sequence Tagged Sites | 1 | 1996 | 94 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2001 | 11695 | 0.040 |
Why?
|
| Phylogeny | 3 | 2009 | 2797 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 18112 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 1586 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2002 | 1869 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 2417 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2003 | 1354 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1996 | 408 | 0.030 |
Why?
|
| Dimerization | 1 | 1996 | 893 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2002 | 3001 | 0.030 |
Why?
|
| Agouti-Related Protein | 2 | 2007 | 98 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2006 | 3020 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5975 | 0.030 |
Why?
|
| Syndrome | 1 | 2000 | 3248 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2002 | 2260 | 0.030 |
Why?
|
| Body Composition | 1 | 2003 | 2400 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 1723 | 0.030 |
Why?
|
| Humans | 19 | 2011 | 742088 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2003 | 113 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 2915 | 0.030 |
Why?
|
| Virus Replication | 1 | 2001 | 2531 | 0.030 |
Why?
|
| Triglycerides | 1 | 2001 | 2450 | 0.030 |
Why?
|
| Base Sequence | 2 | 2010 | 12797 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 2892 | 0.030 |
Why?
|
| Homeostasis | 1 | 2003 | 3335 | 0.030 |
Why?
|
| Cholesterol | 1 | 2001 | 2895 | 0.030 |
Why?
|
| Ghrelin | 2 | 2004 | 266 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 230 | 0.020 |
Why?
|
| tau Proteins | 1 | 2001 | 1860 | 0.020 |
Why?
|
| Tetracycline | 1 | 2011 | 214 | 0.020 |
Why?
|
| Lipids | 1 | 2002 | 3302 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2005 | 2335 | 0.020 |
Why?
|
| Time Factors | 4 | 2011 | 40054 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 74 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1997 | 1806 | 0.020 |
Why?
|
| Lac Operon | 1 | 2009 | 238 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2011 | 360 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 148 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2009 | 375 | 0.020 |
Why?
|
| Nervous System | 1 | 2011 | 553 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2011 | 362 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1675 | 0.020 |
Why?
|
| Guanosine Diphosphate | 1 | 2007 | 85 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2009 | 349 | 0.020 |
Why?
|
| Consanguinity | 1 | 2008 | 456 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 817 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2006 | 248 | 0.020 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2006 | 46 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 9410 | 0.020 |
Why?
|
| Algorithms | 3 | 2011 | 13853 | 0.020 |
Why?
|
| Fertility | 1 | 2010 | 770 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 1407 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2009 | 690 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2005 | 45 | 0.020 |
Why?
|
| Mutation | 3 | 2009 | 29717 | 0.020 |
Why?
|
| Software | 2 | 2009 | 4434 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1831 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 293 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2001 | 8541 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2004 | 67 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2005 | 85 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 2471 | 0.020 |
Why?
|
| Appetite Regulation | 1 | 2005 | 88 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2004 | 137 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 814 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 575 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1777 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 286 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 814 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2009 | 1159 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 258 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2009 | 2633 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2005 | 303 | 0.010 |
Why?
|
| Europe | 1 | 2009 | 3339 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 464 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2002 | 30 | 0.010 |
Why?
|
| Mitochondria | 2 | 2007 | 3520 | 0.010 |
Why?
|
| Apolipoprotein A-II | 1 | 2002 | 39 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2004 | 377 | 0.010 |
Why?
|
| Medulla Oblongata | 1 | 2003 | 243 | 0.010 |
Why?
|
| Phenotype | 2 | 2010 | 16331 | 0.010 |
Why?
|
| DNA | 2 | 2009 | 7289 | 0.010 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2002 | 111 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 415 | 0.010 |
Why?
|
| Neuroglia | 1 | 2007 | 925 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2006 | 1770 | 0.010 |
Why?
|
| Genome | 1 | 2009 | 1803 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2003 | 302 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2010 | 23387 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 1009 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2008 | 2614 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5892 | 0.010 |
Why?
|
| Lipase | 1 | 2002 | 315 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 2187 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2257 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2638 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 3518 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1057 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2000 | 40955 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 2003 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2004 | 1123 | 0.010 |
Why?
|
| Rats | 2 | 2005 | 24265 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 1613 | 0.010 |
Why?
|
| Risk Factors | 2 | 2002 | 72145 | 0.010 |
Why?
|
| Family Health | 1 | 2002 | 1282 | 0.010 |
Why?
|
| Adult | 4 | 2009 | 213712 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 1438 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 15108 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 3293 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2968 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 2126 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6115 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 2818 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 8300 | 0.010 |
Why?
|
| Middle Aged | 3 | 2004 | 213127 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19862 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8436 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14720 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2119 | 0.010 |
Why?
|
| Glucose | 1 | 2004 | 4391 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 1213 | 0.010 |
Why?
|
| Child | 1 | 2000 | 77478 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 15194 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13814 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4328 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7721 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9387 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 29087 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 40450 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16665 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 57683 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7873 | 0.000 |
Why?
|
| Diet | 1 | 2004 | 7923 | 0.000 |
Why?
|
| Aged | 2 | 2004 | 162944 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2009 | 77098 | 0.000 |
Why?
|